Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: Analysis of 3 NHANES cycles (2001-2006)

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Fraser, Abigail ^a   Williams, Dylan ^a   Lawlor, Debbie A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNICITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; RISK FACTOR; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; DIET RESTRICTION; MULTIVARIATE ANALYSIS; NUTRITION; PATHOPHYSIOLOGY; RISK ASSESSMENT; STATISTICS;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FASTING; HUMANS; INSULIN; MULTIVARIATE ANALYSIS; NUTRITION SURVEYS; PARATHYROID HORMONE; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; UNITED STATES; VITAMIN D;

EID: 78649748022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013882     Document Type: Article

References (30)

1. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
2. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349.
3. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. (2008) Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation 117: 503-511.
4. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, et al. (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119: 2765-2771.
5. Ahlstrom T, Hagstrom E, Larsson A, Rudberg C, Lind L, et al. (2009) Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 71: 673-678.
6. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH, et al. (1995) Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8: 894-901.
7. Zittermann A (2006) Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92: 39-48.
8. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, et al. (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30: 2569-2570.
9. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ (2008) Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990- 2000. Diabetes 57: 2619-2625.
10. Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261: 558-565.
11. Zhao G, Ford ES, Li C, (2010) Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003-2006. Diabetes Care 33: 344-347.
12. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al. (2007) Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States: Data From the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165.
13. Holick MF (2007) Vitamin D Deficiency. N Engl J Med 357: 266-281.
14. Poole KE, Reeve J (2005) Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 5: 612-617.
15. Rose GA, Blackburn, Rose, Gillum RF, Prineas RJ (1982) Cardiovascular Survey Methods. Geneva: World Health Organisation.
16. Centers for Disease Control and Prevention (2008 July) Documentation, codebook, and frequesncies: Plasma fasting glucose and insulin. http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/glu_d.pdf. Accessed October 2010.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 139: 137-147.
19. Reis JP, von MD, Kritz-Silverstein D, Wingard DL, Barrett-Connor E (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30: 1549-1555.
20. Reis JP, von MD, Miller ER III (2008) Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159: 41-48.
21. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, et al. (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341: c3691.
22. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069.
23. Taylor EN, Curhan GC, Forman JP (2008) Parathyroid hormone and the risk of incident hypertension. J Hypertens 26: 1390-1394.
24. Cozzolino M, Ketteler M, Zehnder D (2010) The vitamin D system: a crosstalk between the heart and kidney. European Journal of Heart Failure 12: 1031-1041.
25. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, et al. (2009) Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol 170: 88-94.
26. Centers for Disease Control and Prevention (2008 July) Documentation, codebook procedure: Vitamin D. http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/vid_d.pdf. Accessed October 2010.
27. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50: 967-973.
28. Tai K, Need AG, Horowitz M, Chapman IM (2008) Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 24: 279-285.
29. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26: 27-33.
30. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G (2008) Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133-1163.